1887

Abstract

Immunization via the oral route with an attenuated strain expressing a fragment of the measles virus nucleocapsid protein (aa 79–161) via its type III protein secretion system induced a T helper type 1 response in immunized C3H mice, which conferred protection against measles virus-induced encephalitis in a time- and dose-dependent manner.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18834-0
2003-04-01
2024-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/4/vir840775.html?itemId=/content/journal/jgv/10.1099/vir.0.18834-0&mimeType=html&fmt=ahah

References

  1. Bouche F. B., Ertl O. T., Muller C. P. 2002; Neutralizing B cell responses in measles. Viral Immunol 15:451–472
    [Google Scholar]
  2. Fennelly G. J., Flynn J. A. L., ter Meulen V., Liebert U. G., Bloom B. R. 1995; Recombinant Bacille Calmette-Guerin priming against measles. J Infect Dis 172:698–705
    [Google Scholar]
  3. Finke D., Brinckmann U. G., ter Meulen V., Liebert U. G. 1995; Gamma interferon is a major mediator of the antiviral defense in experimental measles virus-induced encephalitis. J Virol 69:5469–5474
    [Google Scholar]
  4. Hilleman M. R. 2001; Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20:651–665
    [Google Scholar]
  5. Igwe E. I., Russmann H., Roggenkamp A., Noll A., Autenrieth I. B., Heesemann J. 1999; Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica . Infect Immun 67:5500–5507
    [Google Scholar]
  6. Jacobi C. A., Roggenkamp A., Rakin A., Zumbihl R., Leitritz L., Heesemann J. 1998; In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol Microbiol 30:865–882
    [Google Scholar]
  7. Katz M. 1995; Clinical spectrum of measles. In Measles Virus pp  1–12 Edited by Billeter M., ter Meulen V. Berlin: Springer;
    [Google Scholar]
  8. Neumeister C., Niewiesk S. 1998; Recognition of measles virus-infected cells by CD8+ T cells depends on the H-2 molecule. J Gen Virol 79:2583–2591
    [Google Scholar]
  9. Niewiesk S., Brinckmann U., Bankamp B., Sirak S., Liebert U. G., ter Meulen V. 1993; Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J Virol 67:75–81
    [Google Scholar]
  10. Polack F. P., Auwaerter P. G., Lee S.-H., Nousari H. C., Valsamakis A., Leiferman K. M., Diwan A., Adams R. J., Griffin D. E. 1999; Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5:629–634
    [Google Scholar]
  11. Polack F. P., Hoffman S. J., Moss W. J., Griffin D. E. 2002; Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis 185:13–19
    [Google Scholar]
  12. Reich A., Erlwein O., Niewiesk S., ter Meulen V., Liebert U. G. 1992; CD4+ T cells control measles virus infection of the central nervous system. Immunology 76:185–191
    [Google Scholar]
  13. Roggenkamp A., Bittner T., Leitritz L., Sing A., Heesemann J. 1997; Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8. Infect Immun 65:4705–4710
    [Google Scholar]
  14. Russmann H., Weissmuller A., Geginat G., Igwe E. I., Roggenkamp A., Bubert A., Goebel W., Hof H., Heesemann J. 2001; Yersinia enterocolitica -mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur J Immunol 30:1375–1384
    [Google Scholar]
  15. Schlereth B., Rose K. J., Buonocore L., ter Meulen V., Niewiesk S. 2000; Successful vaccine-induced seroconversion by single dose immunization in the presence of measles virus specific maternal antibodies. J Virol 74:4652–4657
    [Google Scholar]
  16. Spreng S., Gentschev I., Goebel W., Weidinger G., ter Meulen V., Niewiesk S. 2000; Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis. Microbes Infect 2:1687–1692
    [Google Scholar]
  17. Tober C., Seufert M., Schneider H., Billeter M. A., Johnston I. C. D., Niewiesk S., ter Meulen V., Schneider-Schaulies S. 1998; Expression of measles virus V protein is associated with transcriptional control and pathogenicity. J Virol 72:8124–8132
    [Google Scholar]
  18. van Els C. A. C. M., Nanan R. 2002; T cell responses in acute measles. Viral Immunol 15:435–450
    [Google Scholar]
  19. Weidinger G. 2002; Measles virus-specific T cell immunity in rodent models. Viral Immunol 15:429–434
    [Google Scholar]
  20. Weidinger G., Czub S., Neumeister C., Harriott P., ter Meulen V., Niewiesk S. 2000; Role of CD4+ and CD8+ T cells in the prevention of measles virus induced encephalitis in mice. J Gen Virol 81:2707–2713
    [Google Scholar]
  21. Weidinger G., Henning G., ter Meulen V., Niewiesk S. 2001; Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitis. J Virol 75:3059–3065
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.18834-0
Loading
/content/journal/jgv/10.1099/vir.0.18834-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error